[1]
BASHINI, M., SHAH, S. and DESAI, C. 2022. AN EVALUATION OF ADVERSE DRUG REACTIONS WITH REMDESIVIR IN PATIENTS OF COVID-19. Asian Journal of Pharmaceutical and Clinical Research. 15, 8 (Aug. 2022), 88–91. DOI:https://doi.org/10.22159/ajpcr.2022.v15i8.44985.